Special Drug Use-results Surveillance for long term administration in adult (18 years and older) of CONCERTA, 18mg/ 27mg/ 36mg Tablets

Special Drug Use-results Surveillance for long term administration in adult (18 years and older) of CONCERTA, 18mg/ 27mg/ 36mg Tablets - Special Drug Use-results Surveillance for long term administration in adult (18 years and older) of CONCERTA, 18mg/ 27mg/ 36mg Tablets

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000015900

Enrollment

500

Registered

2014-12-15

Start date

2014-06-09

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Attention deficit hyperactivity disorder (ADHD)

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients of adult(18 years and older) with Attention deficit hyperactivity disorder (ADHD) who are treated with CONCERTA Tablets for the first time

Exclusion criteria

Exclusion criteria: Patients of continuous treatment with CONCERTA Tablets from childhood to adult with ADHD is excluded from the study of the subject

Design outcomes

Primary

Measure	Time frame
Safety(Adverse Drug Reaction) Effectiveness(Clinical Global Impression, CAARS)	—

Countries

Japan

Contacts

Public ContactKeiko Imai

Janssen Pharmaceutical K.K Safety Risk Management Dept.

kimai4@its.jnj.com03-4411-5752

Outcome results